GNE-207 P7-4 Targeting Myddosome Signaling in Waldenström's

Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191

Cocktail Formulation: 0

and the combination of SMI-4a and a mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor was highly synergistic in killing pre-T-LBL cells

Characterization and comparison of the pungent components in commercial Zanthoxylumbungeanum oil and Zanthoxylum schinifolium oil

BAY 1217389 achieves moderate efficacy in monotherapy in tumor xenograft studies

GNE-207 P7-4 Targeting Myddosome Signaling in Waldenström'sGNE 207 is a potent, selective and orally bioavailable inhibitor of the bromodomain of CBP, with an IC50 of 1 nM, exhibits a selectively index of >2500 fold against BRD4 (1). GNE 207 shows excellent CBP potency, with an EC50 of 18 nM for MYC expression in MV 4 11 cells. Product information CAS Number: 2158266 58 9 Molecular Weight: 510. 59 Formula: C29H30N6O3 Chemical Name: 5 {8 [5 acetyl 1 (oxan 4 yl) 1H,4H,5H,6H,7H pyrazolo[4,3 c]pyridin 3